-
Mashup Score: 8
Twenty years ago, the first issue of The Hematologist contained a “Diffusion” article1 titled “A Fine Balance Between Immunity and Cancer,” about a publication
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Smoldering multiple myeloma (SMM) is an asymptomatic condition that occupies a space between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) along the spectrum of clonal plasma cell proliferative disorders. It is not a biologic intermediate stage between MGUS and MM, but rather represents a heterogeneous clinically defined condition in which some patients…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @BloodCancerJnl: Management of smoldering myeloma. https://t.co/oaNtwuYQzG @mvmateos @SagarLonialMD @myelomaMD @VincentRK
-
-
Mashup Score: 3Registration - 2 year(s) ago
Back to Main Entrance Registration for the face-to-face congress in Paris Early Registration until March 15, 2023 Standard Registration from March 16, 2023 and
Source: The 9th COMy World CongressCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @COMyCongress: 🔴The 9th World Congress on Controversies in Multiple Myeloma (COMy) Register TODAY⬇️ https://t.co/KZL425yTei Be sure to…
-
-
Mashup Score: 1MMRF Patient Webinar Series – Multiple Myeloma Precursor Conditions, With Updates - 1601785 - 2 year(s) ago
MMRF Patient Webinar Series – Multiple Myeloma Precursor Conditions, With Updates Wednesday, April 5, 20232:30 PM–3:30 PM (ET)Please join us for a FREE webinar developed to help patients (and their families and caregivers) better understand the multiple myeloma precursor conditions MGUS (monoclonal gammopathy of undetermined significance) and SMM (smoldering multiple myeloma)—including what…
Source: event.webcasts.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @theMMRF: There are FOUR days left until our patient webinar! Don't miss out - register today: https://t.co/EZDdbCoVsi 💬 Multiple #Mye…
-
-
Mashup Score: 42023 International Myeloma Society Annual Meeting: Abstracts - 2 year(s) ago
The Scientific Program Committee invites you to submit an abstract for the 20th International Myeloma Society Annual Meeting, taking place September 27-30, 2023 in Athens, Greece. Abstract Categories for IMS Annual 2023: Treatment of Newly Diagnosed Myeloma- Transplant Eligible Treatment of Newly Diagnosed Myeloma- Non-Transplant Eligible Treatment of Relapsed/Refractory…
Source: events.jspargo.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @Myeloma_Society: The abstract portal for #IMS2023 is open until May 30! Learn more and submit here: https://t.co/RE6KvycgG1 https://t.c…
-
-
Mashup Score: 0SUMMARY - OncLive/Institutional Perspectives in Cancer/Genitourinary Cancers/March 8, 2023/ET - 2 year(s) ago
OncLive® Institutional Perspectives in Cancer: Disease State, Month Day, Year. Oncology Webinar features research and clinical advances in oncology.
Source: event.onclive.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @BasselNazha: Join us on March 8th for a GU med onc update🗞️ @WinshipAtEmory @jackiebrown_MD @bilenma https://t.co/9aIWF8QUtQ
-
-
Mashup Score: 5
Smoldering multiple myeloma (SMM) is an asymptomatic condition that occupies a space between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) along the spectrum of clonal plasma cell proliferative disorders. It is not a biologic intermediate stage between MGUS and MM, but rather represents a heterogeneous clinically defined condition in which some patients…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @VincentRK: 2022 Review on smoldering myeloma. @mvmateos @SagarLonialMD @myelomaMD @BloodCancerJnl #MedTwitter https://t.co/iJ4X6Y6jqQ
-
-
Mashup Score: 14High-Dose Melphalan Is the Tom Brady of the Myeloma World - 2 year(s) ago
Richardson PG, Jacobus SJ, Weller EA, et al. Triplet therapy, transplantation, and maintenance until progression in myeloma. N Engl J Med. 2022;387(2):132-147.
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @BldCancerDoc: High-Dose Melphalan Is the Tom Brady of the Myeloma World @bhemato @szusmani https://t.co/1lgCqTpQSJ
-
-
Mashup Score: 3
Data on a new treatment approach utilizing bispecific monoclonal antibodies targetting B-cell maturation antigen (BCMA) were recently published, yielding very encouraging results in the setting of relapsed and/or refractory multiple myeloma (RRMM). How to safely and effectively deliver this treatment to patients and where it fits in the RRMM treatment paradigm are important questions for the…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @NatRevClinOncol: New article by @DrKrinaPatel & @SagarLonialMD: When an embarrassment of riches isn’t enough https://t.co/SshhbVc6nw #M…
-
-
Mashup Score: 7Scientific Program - 3 year(s) ago
Back to Main Entrance Scientific Program Day 1, Thursday, May 12th
Source: The 8th COMy World CongressCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @COMyCongress: 📢Have you seen our exciting program?https://t.co/knLFCuQJvQ World Congresses on Controversies in Multiple Myeloma (COMy)…
-
RT @MadhavDhodapkar: Then and NowHarnessing Immunity in Myeloma: Wine That Keeps Getting Better? https://t.co/HyjiOcnBeW